Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
REVA Medical
MedTech
Reva returns with $45M to bring its dissolving stent to the US
The California-based outfit went through Chapter 11 bankruptcy proceedings in early 2020 and re-emerged as a private enterprise.
Conor Hale
Aug 10, 2022 11:46am
Reva expands bioresorbable stent footprint in Europe
Jan 8, 2019 11:34am
Reva secures CE mark for bioresorbable scaffold in lower-leg PAD
Jul 30, 2018 12:23pm
Reva gets CE mark for bioresorbable scaffold with thin struts
Feb 26, 2018 9:20am
Reva gets CE mark for drug-eluting bioresorbable scaffold
Apr 5, 2017 4:30am
